Whole-population testing for breast and ovarian cancer gene mutations is cost effective

(Queen Mary University of London) Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news